GLI2 and gastric cancer: Interestingly, Chakrabarti et al. demonstrated that GLI2 promoted the expression of programmed death ligand-1 (PD-L1) to inhibit CD8+ cytotoxic T lymphocyte (CTL) cells’ effector function in gastric cancer [103].